CCB
BNTX icon

Cutter & Co Brokerage’s BioNTech BNTX Stock Holding History

Cutter & Co Brokerage’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,408
Closed -$657K – 227
2022
Q2 		$657K Hold
4,408
– – 0.22% 87
2022
Q1 		$752K Sell
4,408
-189
-4% -$31.8K 0.22% 85
2021
Q4 		$1.19M Sell
4,597
-775
-14% -$212K 0.32% 74
2021
Q3 		$1.47M Sell
5,372
-1,084
-17% -$345K 0.35% 75
2021
Q2 		$1.45M Hold
6,456
– – 0.33% 78
2021
Q1 		$705K Hold
6,456
– – 0.17% 121
2020
Q4 		$526K Hold
6,456
– – 0.14% 139
2020
Q3 		$447K Sell
6,456
-6,969
-52% -$500K 0.13% 138
2020
Q2 		$896K Buy
+13,425
New +$670K 0.29% 84

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cutter & Co Brokerage's BNTX Position: Q3 2022 in Review

Cutter & Co Brokerage sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 4,408 shares — an estimated $657K sold.

Cutter & Co Brokerage first reported a position in BNTX in Q2 2020 and held it in 9 quarters. The position peaked at $1.47M in Q3 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Cutter & Co Brokerage reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
  • Cutter & Co Brokerage sold 4,408 BioNTech shares in Q3 2022, an estimated $657K.
  • Cutter & Co Brokerage first reported a position in BioNTech in Q2 2020 and held it in 9 quarters.
  • Cutter & Co Brokerage's BioNTech position peaked at $1.47M in Q3 2021.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Cutter & Co Brokerage's 13F filing for Q3 2022, filed 3 Nov 2022.